ID

14997

Descripción

This study will evaluate the safety, reactogenicity and immunogenicity of a booster dose of GSK Biologicals' pneumococcal conjugate vaccine compared to Prevenar™ given at 12-18 mo of age to children primed with either pneumococcal vaccine or Prevenar™ in study 105553. Antibody persistence will be evaluated at 8-14 mo after completion of the 3-dose immunization course in study 105553. The immune response to a booster dose of GSK Biologicals' pneumococcal conjugate vaccine will also be evaluated when given at 12-18 mo to subjects not primed with GSK Biologicals' vaccine but with Prevenar™. The study has 3 groups. 1 group of children primed with GSK Biologicals' pneumococcal conjugate vaccine will receive a booster dose of the same vaccine. 2nd group of children primed with Prevenar™ will receive a booster dose of Prevenar™ (control group). 3rd group of children primed with Prevenar™ will receive a booster dose of GSK Biologicals' pneumococcal conjugate vaccine. All children will receive concomitantly a booster dose of DTPa-HBV-IPV/Hib vaccine. NCT00370396 Part: Diary Card: Local Symptoms

Palabras clave

Versiones (2)
  1. 10/5/16 10/5/16 -
  2. 11/5/16 11/5/16 -
Subido en

11 de mayo de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Diary Card: Local Symptoms Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals 10-valent Pneumococcal Conjugate Vaccine NCT00370396

Inglés

Diary Card: Local Symptoms "Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine" NCT00370396

1 formularios  
Identification
Descripción

Identification

Alias
UMLS CUI-1
C1300638
Center number
Descripción

Center number

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1301943
UMLS CUI [1,2]
C0805701
Subject ID
Descripción

Subject ID

Tipo de datos

text

Alias
UMLS CUI [1]
C2348585
Treatment Number
Descripción

Treatment Number

Tipo de datos

text

Alias
UMLS CUI [1]
C1522541
Date of birth
Descripción

Date of birth

Tipo de datos

date

Alias
UMLS CUI [1]
C0421451
Gender
Descripción

Gender

Tipo de datos

text

Alias
UMLS CUI [1]
C0079399
Date of vaccination
Descripción

Vaccination Date

Tipo de datos

date

Alias
UMLS CUI [1]
C1115436
Local Symptoms (At Injection Sites)
Descripción

Local Symptoms (At Injection Sites)

Alias
UMLS CUI-1
C1457887
UMLS CUI-2
C0205276
Type of Vaccine Administered
Descripción

for investigator only

Tipo de datos

integer

Alias
UMLS CUI [1]
C0087111
Injection side
Descripción

for investigator only

Tipo de datos

text

Alias
UMLS CUI [1]
C0441987
Injection site
Descripción

for investigator only

Tipo de datos

integer

Alias
UMLS CUI [1]
C1515974
Local Symptoms
Descripción

Local Symptoms

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1457887
UMLS CUI [1,2]
C0205276
Symptom Size/Intensity Day 0
Descripción

SIZE: Please measure the areatest diameter (in mm). Please contact the study personnel if your child experiences any symptom that raises concern, including injection site puffiness (swelling) diameter >50mm; widespread puffiness (diffuse swelling) or if the size of the injected limb increases (increased limb circumference). Pain 0: Absent 1: Minor reaction to touch interfering with everyday activities. 2: Cries/protests on touch 3: Cries when limb is moved Other local Symptoms 1 :Mild: An adverse event which is easily tolerated by the subject, causing minimal discomfort and not 2:Moderate: An adverse event which is sufficiently discomforting to interfere with normal everyday activities. 3:Severe: An adverse event which prevents normal, everyday activities. (In a young child, such an adverse spontaneously painful event would, for example, prevent attendance at school/kindergarten/a day-care center andwould cause the parents/guardians to seek. medical advice).

Tipo de datos

text

Alias
UMLS CUI [1]
C0456389
UMLS CUI [2]
C0518690
Symptom Size/Intensity Day 1
Descripción

SIZE: Please measure the areatest diameter (in mm). Please contact the study personnel if your child experiences any symptom that raises concern, including injection site puffiness (swelling) diameter >50mm; widespread puffiness (diffuse swelling) or if the size of the injected limb increases (increased limb circumference). Pain 0: Absent 1: Minor reaction to touch interfering with everyday activities. 2: Cries/protests on touch 3: Cries when limb is moved Other local Symptoms 1 :Mild: An adverse event which is easily tolerated by the subject, causing minimal discomfort and not 2:Moderate: An adverse event which is sufficiently discomforting to interfere with normal everyday activities. 3:Severe: An adverse event which prevents normal, everyday activities. (In a young child, such an adverse spontaneously painful event would, for example, prevent attendance at school/kindergarten/a day-care center andwould cause the parents/guardians to seek. medical advice).

Tipo de datos

text

Alias
UMLS CUI [1]
C0456389
UMLS CUI [2]
C0518690
Symptom Size/Intensity Day 2
Descripción

SIZE: Please measure the areatest diameter (in mm). Please contact the study personnel if your child experiences any symptom that raises concern, including injection site puffiness (swelling) diameter >50mm; widespread puffiness (diffuse swelling) or if the size of the injected limb increases (increased limb circumference). Pain 0: Absent 1: Minor reaction to touch interfering with everyday activities. 2: Cries/protests on touch 3: Cries when limb is moved Other local Symptoms 1 :Mild: An adverse event which is easily tolerated by the subject, causing minimal discomfort and not 2:Moderate: An adverse event which is sufficiently discomforting to interfere with normal everyday activities. 3:Severe: An adverse event which prevents normal, everyday activities. (In a young child, such an adverse spontaneously painful event would, for example, prevent attendance at school/kindergarten/a day-care center andwould cause the parents/guardians to seek. medical advice).

Tipo de datos

text

Alias
UMLS CUI [1]
C0456389
UMLS CUI [2]
C0518690
Symptom Size/Intensity Day 3
Descripción

SIZE: Please measure the areatest diameter (in mm). Please contact the study personnel if your child experiences any symptom that raises concern, including injection site puffiness (swelling) diameter >50mm; widespread puffiness (diffuse swelling) or if the size of the injected limb increases (increased limb circumference). Pain 0: Absent 1: Minor reaction to touch interfering with everyday activities. 2: Cries/protests on touch 3: Cries when limb is moved Other local Symptoms 1 :Mild: An adverse event which is easily tolerated by the subject, causing minimal discomfort and not 2:Moderate: An adverse event which is sufficiently discomforting to interfere with normal everyday activities. 3:Severe: An adverse event which prevents normal, everyday activities. (In a young child, such an adverse spontaneously painful event would, for example, prevent attendance at school/kindergarten/a day-care center andwould cause the parents/guardians to seek. medical advice).

Tipo de datos

text

Alias
UMLS CUI [1]
C0456389
UMLS CUI [2]
C0518690
Ongoing after Day 3
Descripción

Ongoing after Day 3

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0449238
Date of last Symptoms
Descripción

Date of last Symptoms

Tipo de datos

date

Alias
UMLS CUI [1,1]
C1457887
UMLS CUI [1,2]
C0011008
Medically Attended visit
Descripción

Medically Attended visit

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0545082
Other Local Symptoms
Descripción

Other Local Symptoms

Description - please specify side(s) and site(s)
Descripción

Description - please specify side(s) and site(s)

Tipo de datos

text

Alias
UMLS CUI [1]
C0441987
UMLS CUI [2]
C1515974
Intensity
Descripción

Intensity

Tipo de datos

integer

Alias
UMLS CUI [1]
C0522510
Start date
Descripción

Start date

Tipo de datos

date

Unidades de medida
  • dd/mm/yy
Alias
UMLS CUI [1]
C0808070
dd/mm/yy
End date
Descripción

End date

Tipo de datos

date

Unidades de medida
  • dd/mm/yy
Alias
UMLS CUI [1]
C0806020
dd/mm/yy
Is the symptom persistent?
Descripción

Ongoing

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0549178
Medically Attended visit
Descripción

Medically Attended visit

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0545082
Volver a la parte superior de la página

Similar models

Diary Card: Local Symptoms "Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine" NCT00370396

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Identification
C1300638 (UMLS CUI-1)
Center number
Item
Center number
text
C1301943 (UMLS CUI [1,1])
C0805701 (UMLS CUI [1,2])
Subject ID
Item
Subject ID
text
C2348585 (UMLS CUI [1])
Treatment Number
Item
Treatment Number
text
C1522541 (UMLS CUI [1])
Date of birth
Item
Date of birth
date
C0421451 (UMLS CUI [1])
Item
Gender
text
C0079399 (UMLS CUI [1])
Gender
Code List
Gender
CL Item
Male (m)
CL Item
Female (f)
Vaccination Date
Item
Date of vaccination
date
C1115436 (UMLS CUI [1])
Item Group
Local Symptoms (At Injection Sites)
C1457887 (UMLS CUI-1)
C0205276 (UMLS CUI-2)
Item
Type of Vaccine Administered
integer
C0087111 (UMLS CUI [1])
Type of Vaccine Administered
Code List
Type of Vaccine Administered
CL Item
10Pn-PD-DiT or Prevenar vaccine (1)
CL Item
DTPa-HBV-IPV/Hib vaccine (2)
Item
Injection side
text
C0441987 (UMLS CUI [1])
Injection side
Code List
Injection side
CL Item
Left  (L)
CL Item
Right (R)
Item
Injection site
integer
C1515974 (UMLS CUI [1])
Injection site
Code List
Injection site
CL Item
Arm (1)
CL Item
thigh (3)
CL Item
buttock (6)
Item
Local Symptoms
integer
C1457887 (UMLS CUI [1,1])
C0205276 (UMLS CUI [1,2])
Local Symptoms
Code List
Local Symptoms
CL Item
Redness (1)
CL Item
Swelling (2)
CL Item
Pain (3)
Symptom Size/Intensity Day 0
Item
Symptom Size/Intensity Day 0
text
C0456389 (UMLS CUI [1])
C0518690 (UMLS CUI [2])
Symptom Size/Intensity Day 1
Item
Symptom Size/Intensity Day 1
text
C0456389 (UMLS CUI [1])
C0518690 (UMLS CUI [2])
Symptom Size/Intensity Day 2
Item
Symptom Size/Intensity Day 2
text
C0456389 (UMLS CUI [1])
C0518690 (UMLS CUI [2])
Symptom Size/Intensity Day 3
Item
Symptom Size/Intensity Day 3
text
C0456389 (UMLS CUI [1])
C0518690 (UMLS CUI [2])
Ongoing after Day 3
Item
Ongoing after Day 3
boolean
C0449238 (UMLS CUI [1])
Date of last Symptoms
Item
Date of last Symptoms
date
C1457887 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Medically Attended visit
Item
Medically Attended visit
boolean
C0545082 (UMLS CUI [1])
Item Group
Other Local Symptoms
Description - please specify side(s) and site(s)
Item
Description - please specify side(s) and site(s)
text
C0441987 (UMLS CUI [1])
C1515974 (UMLS CUI [2])
Item
Intensity
integer
C0522510 (UMLS CUI [1])
Intensity
Code List
Intensity
CL Item
Mild: An adverse event which is easily tolerated by the subject, causing minimal discomfort and not (1)
CL Item
Moderate: An adverse event which is sufficiently discomforting to interfere with normal everyday activities. (2)
CL Item
Severe: An adverse event which prevents normal, everyday activities. (In a young child, such an adverse spontaneously painful event would, for example, prevent attendance at school/kindergarten/a day-care center and would cause the parents/guardians to seek. medical advice). (3)
Start date
Item
Start date
date
C0808070 (UMLS CUI [1])
End date
Item
End date
date
C0806020 (UMLS CUI [1])
Ongoing
Item
Is the symptom persistent?
boolean
C0549178 (UMLS CUI [1])
Medically Attended visit
Item
Medically Attended visit
boolean
C0545082 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial